Skye Bioscience, Inc. (SKYE) insider trading.
In Q3 2026, insiders at Skye Bioscience, Inc. reported 31 non-derivative transactions on 7 Forms 3, 4 and 5: 0 open-market purchases and 30 sales worth $889K.
- Transactions
- 31
- Purchases (P)
- 0
- Sales (S)
- 30
- Net shares, P minus S
- -1,115,622
- Insiders
- 5
- Last filed
- 2026-09-24
Insiders
| Insider | Relationship | Transactions | Buys | Sales |
|---|---|---|---|---|
| Schwab Andrew J. | Director, TenPercentOwner | 15 | 0 | 15 |
| 5AM Partners II, LLC / 5AM Partners VII, LLC / ROCKLAGE SCOTT M / 5AM Ventures II LP / 5AM CO-INVESTORS II LP / PARMAR KUSH / 5AM Ventures VII, L.P. / DIEKMAN JOHN D | TenPercentOwner | 9 | 0 | 9 |
| 5AM Ventures II LP / 5AM Partners VII, LLC / 5AM CO-INVESTORS II LP / PARMAR KUSH / DIEKMAN JOHN D / ROCKLAGE SCOTT M / 5AM Partners II, LLC / 5AM Ventures VII, L.P. | TenPercentOwner | 4 | 0 | 4 |
| PARMAR KUSH / 5AM Ventures II LP / 5AM Partners II, LLC / DIEKMAN JOHN D / 5AM Partners VII, LLC / 5AM CO-INVESTORS II LP / ROCKLAGE SCOTT M / 5AM Ventures VII, L.P. | TenPercentOwner | 2 | 0 | 2 |
| Dhillon Punit | Director, Officer · Chief Executive Officer | 1 | 0 | 0 |
Transactions
| Date | Insider | Code | Shares | Price | Owned after | Filing |
|---|---|---|---|---|---|---|
| 2026-09-23 | 5AM Ventures II LP / 5AM Partners VII, LLC / 5AM CO-INVESTORS II LP / PARMAR KUSH / DIEKMAN JOHN D / ROCKLAGE SCOTT M / 5AM Partners II, LLC / 5AM Ventures VII, L.P. | S (D) | 4,528 | $1.61 | 0 | Form 4 |
| 2026-09-23 | 5AM Ventures II LP / 5AM Partners VII, LLC / 5AM CO-INVESTORS II LP / PARMAR KUSH / DIEKMAN JOHN D / ROCKLAGE SCOTT M / 5AM Partners II, LLC / 5AM Ventures VII, L.P. | S (D) | 114,851 | $1.61 | 0 | Form 4 |
| 2026-09-23 | Schwab Andrew J. | S (D) | 4,528 | $1.61 | 0 | Form 4 |
| 2026-09-23 | Schwab Andrew J. | S (D) | 114,851 | $1.61 | 0 | Form 4 |
| 2026-09-22 | 5AM Ventures II LP / 5AM Partners VII, LLC / 5AM CO-INVESTORS II LP / PARMAR KUSH / DIEKMAN JOHN D / ROCKLAGE SCOTT M / 5AM Partners II, LLC / 5AM Ventures VII, L.P. | S (D) | 1,088 | $1.65 | 4,528 | Form 4 |
| 2026-09-22 | 5AM Ventures II LP / 5AM Partners VII, LLC / 5AM CO-INVESTORS II LP / PARMAR KUSH / DIEKMAN JOHN D / ROCKLAGE SCOTT M / 5AM Partners II, LLC / 5AM Ventures VII, L.P. | S (D) | 27,612 | $1.65 | 114,851 | Form 4 |
| 2026-09-22 | Schwab Andrew J. | S (D) | 1,088 | $1.65 | 4,528 | Form 4 |
| 2026-09-22 | Schwab Andrew J. | S (D) | 27,612 | $1.65 | 114,851 | Form 4 |
| 2026-09-16 | PARMAR KUSH / 5AM Ventures II LP / 5AM Partners II, LLC / DIEKMAN JOHN D / 5AM Partners VII, LLC / 5AM CO-INVESTORS II LP / ROCKLAGE SCOTT M / 5AM Ventures VII, L.P. | S (D) | 1,285 | $1.91 | 5,616 | Form 4 |
| 2026-09-16 | PARMAR KUSH / 5AM Ventures II LP / 5AM Partners II, LLC / DIEKMAN JOHN D / 5AM Partners VII, LLC / 5AM CO-INVESTORS II LP / ROCKLAGE SCOTT M / 5AM Ventures VII, L.P. | S (D) | 32,607 | $1.91 | 142,463 | Form 4 |
| 2026-09-16 | Schwab Andrew J. | S (D) | 32,607 | $1.91 | 142,463 | Form 4 |
| 2026-09-16 | Schwab Andrew J. | S (D) | 1,285 | $1.91 | 5,616 | Form 4 |
| 2026-08-20 | 5AM Partners II, LLC / 5AM Partners VII, LLC / ROCKLAGE SCOTT M / 5AM Ventures II LP / 5AM CO-INVESTORS II LP / PARMAR KUSH / 5AM Ventures VII, L.P. / DIEKMAN JOHN D | S (D) | 46 | $0.32 | 55,208 | Form 4 |
| 2026-08-20 | 5AM Partners II, LLC / 5AM Partners VII, LLC / ROCKLAGE SCOTT M / 5AM Ventures II LP / 5AM CO-INVESTORS II LP / PARMAR KUSH / 5AM Ventures VII, L.P. / DIEKMAN JOHN D | S (D) | 6,495 | $0.32 | 7,850,155 | Form 4 |
| 2026-08-20 | 5AM Partners II, LLC / 5AM Partners VII, LLC / ROCKLAGE SCOTT M / 5AM Ventures II LP / 5AM CO-INVESTORS II LP / PARMAR KUSH / 5AM Ventures VII, L.P. / DIEKMAN JOHN D | S (D) | 1,159 | $0.32 | 1,400,560 | Form 4 |
| 2026-08-20 | Schwab Andrew J. | S (D) | 1,159 | $0.32 | 1,400,560 | Form 4 |
| 2026-08-20 | Schwab Andrew J. | S (D) | 6,495 | $0.32 | 7,850,155 | Form 4 |
| 2026-08-20 | Schwab Andrew J. | S (D) | 46 | $0.32 | 55,208 | Form 4 |
| 2026-08-19 | 5AM Partners II, LLC / 5AM Partners VII, LLC / ROCKLAGE SCOTT M / 5AM Ventures II LP / 5AM CO-INVESTORS II LP / PARMAR KUSH / 5AM Ventures VII, L.P. / DIEKMAN JOHN D | S (D) | 10,255 | $0.35 | 1,401,719 | Form 4 |
| 2026-08-19 | 5AM Partners II, LLC / 5AM Partners VII, LLC / ROCKLAGE SCOTT M / 5AM Ventures II LP / 5AM CO-INVESTORS II LP / PARMAR KUSH / 5AM Ventures VII, L.P. / DIEKMAN JOHN D | S (D) | 57,476 | $0.35 | 7,856,650 | Form 4 |
| 2026-08-19 | 5AM Partners II, LLC / 5AM Partners VII, LLC / ROCKLAGE SCOTT M / 5AM Ventures II LP / 5AM CO-INVESTORS II LP / PARMAR KUSH / 5AM Ventures VII, L.P. / DIEKMAN JOHN D | S (D) | 409 | $0.35 | 55,254 | Form 4 |
| 2026-08-19 | Schwab Andrew J. | S (D) | 57,476 | $0.35 | 7,856,650 | Form 4 |
| 2026-08-19 | Schwab Andrew J. | S (D) | 409 | $0.35 | 55,254 | Form 4 |
| 2026-08-19 | Schwab Andrew J. | S (D) | 10,255 | $0.35 | 1,401,719 | Form 4 |
| 2026-08-18 | 5AM Partners II, LLC / 5AM Partners VII, LLC / ROCKLAGE SCOTT M / 5AM Ventures II LP / 5AM CO-INVESTORS II LP / PARMAR KUSH / 5AM Ventures VII, L.P. / DIEKMAN JOHN D | S (D) | 45,090 | $0.38 | 1,411,974 | Form 4 |
| 2026-08-18 | 5AM Partners II, LLC / 5AM Partners VII, LLC / ROCKLAGE SCOTT M / 5AM Ventures II LP / 5AM CO-INVESTORS II LP / PARMAR KUSH / 5AM Ventures VII, L.P. / DIEKMAN JOHN D | S (D) | 1,830 | $0.38 | 55,663 | Form 4 |
| 2026-08-18 | 5AM Partners II, LLC / 5AM Partners VII, LLC / ROCKLAGE SCOTT M / 5AM Ventures II LP / 5AM CO-INVESTORS II LP / PARMAR KUSH / 5AM Ventures VII, L.P. / DIEKMAN JOHN D | S (D) | 253,080 | $0.38 | 7,914,126 | Form 4 |
| 2026-08-18 | Schwab Andrew J. | S (D) | 253,080 | $0.38 | 7,914,126 | Form 4 |
| 2026-08-18 | Schwab Andrew J. | S (D) | 1,830 | $0.38 | 55,663 | Form 4 |
| 2026-08-18 | Schwab Andrew J. | S (D) | 45,090 | $0.38 | 1,411,974 | Form 4 |
| 2026-08-07 | Dhillon Punit | A (A) | 1,090,000 | $0 | 1,419,823 | Form 4 |
Transaction codes in this quarter
Get SKYE insider transactions through the API
Request with your API key
curl "https://sec-api.dev/api/v1/insider-transactions?period=2026q3&cik=1516551&limit=100" \
-H "Authorization: Bearer $SEC_API_KEY"Insider trading API guide · SKYE company page · Skye Bioscience, Inc. on SEC.gov
Questions
Are insiders buying or selling Skye Bioscience, Inc. (SKYE)?
In Q3 2026, insiders at Skye Bioscience, Inc. reported 31 non-derivative transactions on 7 Forms 3, 4 and 5: 0 open-market purchases and 30 sales worth $889K. Grants, tax withholding and option exercises are counted as transactions but are not purchases or sales.
Where do these Skye Bioscience, Inc. insider trades come from?
From the SEC Insider Transactions Data Sets for Q3 2026, which republish the Forms 3, 4 and 5 filed on EDGAR. Each row links to its filing on SEC.gov.
Source: SEC Insider Transactions Data Sets, Q3 2026, retrieved 2026-10-27. Footnotes, derivative holdings and amendments are in the linked filings. Not investment advice.
Plain-text version for agents and LLMs: /insider-trading/skye.md
Independent. Not affiliated with, endorsed by, or sponsored by the U.S. Securities and Exchange Commission. Data is reproduced from public SEC filings and datasets. Not investment advice.